XEns-CKD: An Explainable Ensemble-Based Approach for Chronic Kidney Disease Stage Detection

Researchers propose XEns-CKD, an ensemble vision transformer-based scheme that classifies chronic kidney disease (CKD) stages from ultrasound images with 86.36% accuracy, a 4% improvement over existing methods. The model uses explainable AI techniques including LIME, LRP, Attention-Min, and Attention-Max to identify and interpret kidney regions affected by CKD progression, enhancing clinical trust.

arXiv:2608.07561v1 Announce Type: new Abstract: Chronic kidney disease CKD is a silent disease. Its progression may not significantly hamper a person's daily routine. Human kidney function can be classified as normal or as one of the five stages of CKD. Early detection of the CKD stage can help patients understand the functional status of their kidneys and follow medical advice to slow CKD progression. In this paper, we propose XEns-CKD, a novel ensemble vision transformer-based scheme for CKD stage classification using ultrasound images. Three ViTs were trained on a private ultrasound image dataset using different training parameters. The performance of each ViT was evaluated using macro sensitivity, macro specificity, macro precision, macro F1-score, macro Youden index, the Matthews correlation coefficient MCC , and macro balanced accuracy. The ensemble model achieved an overall classification accuracy of 86.36%. This work also emphasizes identifying and interpreting kidney regions affected by CKD progression. Explainable artificial intelligence techniques, including LIME, LRP, Attention-Min, and Attention-Max, were used to improve model transparency and clinical trust. An attention map combining the Attention-Min and Attention-Max results effectively identified and interpreted kidney regions affected during CKD progression from one stage to another. The attention map also highlighted the effects of CKD progression in these regions. Compared with existing methods, the proposed method classified the five CKD stages and normal kidney status with a 4% improvement in accuracy.